SEC Form 4 · accession 0000899243-18-018136
ORAGENICS INC · OGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fred Telling
Director
Period of report
Jun 22, 2018
Accepted (ET)
Jun 26, 2018 · 4:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001174940
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 22, 2018 | A | 4,000 | $0.00 | A | 139,538 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Employee Director Option (Right to Buy)F2 | $1.52 | Jun 22, 2018 | A | 14,000 | A | Jun 22, 2019 | Jun 22, 2028 | Common Stock | 14,000 | 14,000 | D |
Explanation of responses
- F1Represents an award of restricted stock in connection with service to the Company as a director pursuant to the 2012 Equity Incentive Plan that vests immediately.
- F2Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a director. The options vest one year from the grant date. The option exercise price is the closing price on the date of the grant, June 22, 2018.
Remarks
*These amounts reflect the reverse stock split effective January 19, 2018.